Wharton Stories: Health Care

“We have a read to admit philosophy, which means that in every application we are looking for reasons to admit you and not reasons to deny you. We are looking for your best day and not your worst.” – Blair Mannix, Director of Admissions

Application Tips from the MBA Admissions Committee

From donations to delivery services for at-risk populations, the Wharton community is joining in the fight against the pandemic.

How Wharton Students Are Supporting COVID-19 Relief Efforts

All Penn and Wharton undergrads and grads can apply for the sought-after WISE Fellowship, a paid experiential learning opportunity in social impact consulting or research.

How to Gain Real-World Social Impact Experience While You’re Still a Student

At the competition kick-off in September, Penn researchers and last year’s Y-Prize runner-up spoke on new inventions, taking the innovative approach, and why participation matters.

Y-Prize Calls On Entrepreneurs to Reimagine Nature-Inspired Tech

After founding her own birth control startup, Natasha Doherty, W’18, joined medical professionals and top academics for a review of leading research in women’s sexual and reproductive health.

A Social Entrepreneur’s Inside Look at the Contraceptive Technology Conference

A panelist at the 2018 Penn Health Policy Retreat, Health Care Management Prof. Ingrid Nembhard discussed her new research on how a new role for nurses may be one way to address care coordination failures in health care.

Prof. Ingrid Nembhard Discusses Team Dynamics in Health Care Coordination

Cellview Science team members Henry Zhou, C’18, Ellen Naruse, W’18, and Michael Lee, W’18, talk about the winning factors that helped them succeed in the Y-Prize Competition.

Y-Prize Winners Share Their 5 Tips for Success in a Startup Competition

Student teams came together at Penn’s Singh Center for Nanotechnology to battle it out for the 2018 Y-Prize, where nanoscale innovation was a running theme.

Biomedical Innovation Dominates the Y-Prize Finale

Glaucoma is the second leading cause of blindness in the world and currently has no cure. VisiPlate is a nanoscale, ocular implant that stops blindness in Open Angle Glaucoma patients.

How VisiPlate Is Curing Blindness With Nanotechnology

Simultaneously foreign and surprisingly comfortable, Kigali quickly became a city of familiarity, an urban island tucked amongst lush green hills and glistening lakes.

Roaming Rwanda: How GRIP Gave This Wharton Undergraduate A Glimpse Into Global Health